Deutsche Bank
APYX icon

Deutsche Bank’s Apyx Medical APYX Stock Holding History

Deutsche Bank’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,664
Closed -$116K – 4126
2022
Q1 		$116K Sell
17,664
-2,020
-10% -$19.9K ﹤0.01% 3527
2021
Q4 		$252K Sell
19,684
-114
-0.6% -$1.59K ﹤0.01% 3262
2021
Q3 		$274K Sell
19,798
-575
-3% -$6.05K ﹤0.01% 3396
2021
Q2 		$210K Sell
20,373
-1,402
-6% -$13.9K ﹤0.01% 3758
2021
Q1 		$211K Sell
21,775
-2,028
-9% -$20.3K ﹤0.01% 3607
2020
Q4 		$172K Buy
23,803
+6,721
+39% +$44.5K ﹤0.01% 3547
2020
Q3 		$80K Buy
17,082
+1,614
+10% +$7.99K ﹤0.01% 3648
2020
Q2 		$85K Buy
15,468
+4,905
+46% +$20.4K ﹤0.01% 3529
2020
Q1 		$38K Sell
10,563
-672
-6% -$4.51K ﹤0.01% 3662
2019
Q4 		$94K Buy
11,235
+2,395
+27% +$17.3K ﹤0.01% 3606
2019
Q3 		$58K Sell
8,840
-10,188
-54% -$72.3K ﹤0.01% 3849
2019
Q2 		$127K Sell
19,028
-22,730
-54% -$124K ﹤0.01% 4078
2019
Q1 		$263K Buy
41,758
+30,725
+278% +$238K ﹤0.01% 3844
2018
Q4 		$71K Sell
11,033
-47,575
-81% -$288K ﹤0.01% 4346
2018
Q3 		$416K Buy
+58,608
New +$326K ﹤0.01% 3881
2017
Q2 		– Sell
-3,000
Closed -$8K – 4917
2017
Q1 		$8K Sell
3,000
-2,428
-45% -$8.06K ﹤0.01% 4645
2016
Q4 		$19K Buy
5,428
+4,492
+480% +$20K ﹤0.01% 4594
2016
Q3 		$4K Buy
936
+686
+274% +$2.23K ﹤0.01% 4771
2016
Q2 		$0 Buy
+250
New +$434 ﹤0.01% 5158
2013
Q4 		– Sell
-1
Closed – – 5387
2013
Q3 		$0 Buy
+1
New +$3 ﹤0.01% 5520

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
IP
Invenire Partners Ridgefield, Connecticut $65.4M AUM 18.1% 1-Year Est. Return

Deutsche Bank's APYX Position: Q2 2022 in Review

Deutsche Bank sold out of Apyx Medical (APYX) in Q2 2022, closing a stake of 17,664 shares — an estimated $116K sold.

Deutsche Bank first reported a position in APYX in Q3 2013 and held it in 20 quarters. The position peaked at $416K in Q3 2018. 63 funds tracked by Wall St. Rank hold APYX as of Q2 2022.

  • Deutsche Bank reported no remaining Apyx Medical position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 17,664 Apyx Medical shares in Q2 2022, an estimated $116K.
  • Deutsche Bank first reported a position in Apyx Medical in Q3 2013 and held it in 20 quarters.
  • Deutsche Bank's Apyx Medical position peaked at $416K in Q3 2018.
  • 63 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.